SHORT and LONG TERM EFFECTS of a DPP-4 INHIBITOR VERSUS BEDTIME NPH INSULIN as ADD-ON THERAPY in PATIENTS WITH TYPE 2 DIABETES.

CONCLUSION: The use of either NPH insulin or a DPP-4 inhibitor as add-on treatments improves glucose control in patients with T2D failing on metformin plus glyburide therapy. The results were not attributed to a permanent improvement in alpha or beta cell function in patients with long-duration diabetes.
PMID: 27928958 [PubMed - as supplied by publisher]

Source: Current Pharmaceutical Design - December 7, 2016 Category: Drugs & Pharmacology Authors: da Silva GM, Nogueira KC, Fukui RT, Correia MR, Dos Santos RF, da Silva ME Tags: Curr Pharm Des Source Type: research